Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-16

Clinical Trial Update: Effect of Antihistamines on Ureteral Stent-Related Symptoms [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether antihistamines relieve ureteral stent-related symptoms in nephrolithiasis; results posted in 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Antihistamines (unspecified) (antihistamine)

Snippet

Sponsor: Columbia University | Conditions: Nephrolithiasis | Phase 2 | Status: COMPLETED | Results posted: 2025-07-16